This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1962 Oct:5:502-12.

doi: 10.1002/art.1780050507.

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

E B HAMILTON, J T SCOTT

PMID: 13904103
DOI: 10.1002/art.1780050507

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

E B HAMILTON et al. Arthritis Rheum. 1962 Oct.

. 1962 Oct:5:502-12.

doi: 10.1002/art.1780050507.

Authors

E B HAMILTON, J T SCOTT

PMID: 13904103
DOI: 10.1002/art.1780050507

No abstract available

PubMed Disclaimer

Similar articles

Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.
SCHERBEL AL, SCHUCHTER SL, HARRISON JW. SCHERBEL AL, et al. Cleve Clin Q. 1957 Apr;24(2):98-104. doi: 10.3949/ccjm.24.2.98. Cleve Clin Q. 1957. PMID: 13427154 No abstract available.
Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis.
SCULL E. SCULL E. Arthritis Rheum. 1962 Feb;5:30-6. doi: 10.1002/art.1780050105. Arthritis Rheum. 1962. PMID: 13910104 No abstract available.
Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases.
SCHERBEL AL, HARRISON JW, ATDJIAN M. SCHERBEL AL, et al. Cleve Clin Q. 1958 Apr;25(2):95-111. doi: 10.3949/ccjm.25.2.95. Cleve Clin Q. 1958. PMID: 13523829 No abstract available.
Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM. Aylward JM. J Am Optom Assoc. 1993 Nov;64(11):787-97. J Am Optom Assoc. 1993. PMID: 8120333 Review.
Rheumatoid arthritis.
[No authors listed] [No authors listed] JAMA. 1973 Apr 30;224(5 Suppl):687-70. JAMA. 1973. PMID: 4573028 Review. No abstract available.

See all similar articles

Cited by

Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?
Kukreja RC, Wang R, Koka S, Das A, Samidurai A, Xi L. Kukreja RC, et al. Mol Cell Biochem. 2023 Mar;478(3):679-696. doi: 10.1007/s11010-022-04520-2. Epub 2022 Aug 29. Mol Cell Biochem. 2023. PMID: 36036333 Free PMC article. Review.
Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.
[No authors listed] [No authors listed] Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):1-60. doi: 10.1136/ard.41.suppl_1.1-a. Ann Rheum Dis. 1982. PMID: 7065738 Free PMC article. No abstract available.
The long-term effects of treating rheumatoid arthritis.
Scott DL, Coulton BL, Chapman JH, Bacon PA, Popert AJ. Scott DL, et al. J R Coll Physicians Lond. 1983 Jan;17(1):79-85. J R Coll Physicians Lond. 1983. PMID: 6402590 Free PMC article. No abstract available.
In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?
Rooney RJ, Buchanan WW. Rooney RJ, et al. Clin Rheumatol. 1990 Sep;9(3):315-8. doi: 10.1007/BF02114390. Clin Rheumatol. 1990. PMID: 2261731 No abstract available.
Rational use of disease-modifying antirheumatic drugs.
Furst DE. Furst DE. Drugs. 1990 Jan;39(1):19-37. doi: 10.2165/00003495-199039010-00003. Drugs. 1990. PMID: 2178910 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley